Molecular Genetics of Clear-Cell Renal Cell Carcinoma

por Brugarolas, James
Publicado 2014

PBRM1 and BAP1 as Novel Targets for Renal Cell Carcinoma

por Brugarolas, James
Publicado en Cancer J (2013)

TFEB: A novel mTORC1 effector implicated in lysosome biogenesis, endocytosis and autophagy

por Peña-Llopis, Samuel, Brugarolas, James
Publicado 2011

Simultaneous isolation of high-quality DNA, RNA, miRNA and proteins from tissues for genomic applications

por Peña-Llopis, Samuel, Brugarolas, James
Publicado 2013

p21 Is a Critical CDK2 Regulator Essential for Proliferation Control in Rb-deficient Cells

por Brugarolas, James, Bronson, Roderick T., Jacks, Tyler
Publicado 1998

Succination of Keap1 and activation of Nrf2-dependent antioxidant pathways in FH-deficient papillary renal cell carcinoma type-2

por Kinch, Lisa, Grishin, Nick V., Brugarolas, James
Publicado 2011

Establishing a Human Renal Cell Carcinoma Tumorgraft Platform for Preclinical Drug Testing

por Pavía-Jiménez, Andrea, Tcheuyap, Vanina Toffessi, Brugarolas, James
Publicado en Nat Protoc (2014)

DEFOR: depth- and frequency-based somatic copy number alteration detector

por Zhang, He, Zhan, Xiaowei, Brugarolas, James, Xie, Yang
Publicado en Bioinformatics (2019)

Renal Cell Carcinoma Pseudoprogression with Clinical Deterioration: To Hospice and Back

por Elias, Roy, Kapur, Payal, Pedrosa, Ivan, Brugarolas, James
Publicado en Clin Genitourin Cancer (2018)

Next Generation Sequencing in Renal Cell Carcinoma: Towards Precision Medicine

por Elias, Roy, Sharma, Akanksha, Singla, Nirmish, Brugarolas, James
Publicado en Kidney Cancer J (2019)

What morphology can teach us about renal cell carcinoma clonal evolution

por Kapur, Payal, Christie, Alana, Rajaram, Satwik, Brugarolas, James
Publicado en Kidney Cancer J (2020)

REDD1/DDIT4-independent mTORC1 Inhibition and Apoptosis by Glucocorticoids in Thymocytes

por Wolff, Nicholas C., McKay, Renée M., Brugarolas, James
Publicado en Mol Cancer Res (2014)

What is the role of nephrectomy following complete response to checkpoint inhibitors?

por Woldu, Solomon L., Brugarolas, James, Kapur, Payal, Margulis, Vitaly
Publicado en Urol Case Rep (2018)

The complex relationship between TFEB transcription factor phosphorylation and subcellular localization

por Puertollano, Rosa, Ferguson, Shawn M, Brugarolas, James, Ballabio, Andrea
Publicado en EMBO J (2018)

Checking the Hippo in sarcomatoid renal cell carcinoma with immunotherapy

por Hwang, Joyce K., Agarwal, Neeraj, Brugarolas, James, Zhang, Tian
Publicado en Clin Cancer Res (2020)

Cooperation and antagonism among cancer genes: the renal cancer paradigm

por Peña-Llopis, Samuel, Christie, Alana, Xie, Xian-Jin, Brugarolas, James
Publicado 2013

Personalized Management of Advanced Kidney Cancer

por Graham, Jeffrey, Heng, Daniel Y. C., Brugarolas, James, Vaishampayan, Ulka
Publicado en Am Soc Clin Oncol Educ Book (2018)

Involvement of p53 and p21 in Cellular Defects and Tumorigenesis in Atm(−/−) Mice

por Xu, Yang, Yang, Eva Marie, Brugarolas, James, Jacks, Tyler, Baltimore, David
Publicado 1998

Multistep regulation of TFEB by MTORC1

por Vega-Rubin-de-Celis, Silvia, Peña-Llopis, Samuel, Konda, Meghan, Brugarolas, James
Publicado en Autophagy (2017)

Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G(1) arrest after γ-irradiation

por Brugarolas, James, Moberg, Ken, Boyd, Scott D., Taya, Yoichi, Jacks, Tyler, Lees, Jacqueline A.
Publicado 1999